You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 7,252,839


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,252,839
Title:Delivery system and a manufacturing process of a delivery system
Abstract: A delivery system including a body construction (7) and at least one capsule (8) containing a pharmaceutical composition, the capsule having at least a first end and a second end. The body construction (7, 12, 34) has at least two locking parts (9, 10), each locking part (9, 10) having at least a first end and a second end, the first end of each locking part (9, 10) having a surface adapted to face and cover one of the at least first and second ends of the capsule (8). The diameter of at least one of the locking parts varies along its length between the first end and the second end, and the capsule (8) is mounted between the at least two locking parts. Also disclosed is a manufacturing process of a delivery system, the system including a body construction and at least one capsule containing a pharmaceutical composition.
Inventor(s): Hallinen; Esa (Lempaala{umlaut over ( )}, FI), Lyytikainen; Heikki (Naantali, FI), Jarvela; Pentti (Lahti, FI), Kivi; Ilkka (Pirkkala, FI)
Assignee: Schering Oy (Turku, FI)
Application Number:10/528,237
Patent Claim Types:
see list of patent claims
Composition; Dosage form; Delivery; Process;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 7,252,839

Introduction

When analyzing a patent, it is crucial to delve into its scope, claims, and the broader patent landscape to fully comprehend its implications and significance. This article will provide a detailed analysis of United States Patent 7,252,839, focusing on its claims, the technological context, and the relevant patent landscape.

Patent Overview

United States Patent 7,252,839, hereafter referred to as the '839 patent, is a utility patent granted by the U.S. Patent and Trademark Office (USPTO). To begin, it is essential to identify the key elements of the patent:

Title and Abstract

The title and abstract of the patent provide a preliminary understanding of the invention. While the specific details of the '839 patent are not provided in the sources, typically, the title and abstract summarize the main invention and its purpose.

Background of the Invention

The background section explains the context and prior art related to the invention. This section helps in understanding the problem the patent aims to solve and how it differs from existing solutions.

Claims Analysis

Independent and Dependent Claims

Patent claims are the most critical part of a patent as they define the scope of the invention. Independent claims stand alone and define the invention broadly, while dependent claims build upon the independent claims and provide more specific details.

  • Independent Claims: These claims outline the core elements of the invention and are typically broader in scope.
  • Dependent Claims: These claims narrow down the invention by adding specific features or limitations to the independent claims.

Claim Construction

Claim construction is the process of interpreting the meaning of the claims. This involves understanding the terminology used, the relationships between different claim elements, and how they interact with each other.

Technological Context

Field of the Invention

Understanding the field in which the patent operates is vital. This includes identifying the industry, the specific technology involved, and how the invention fits into the existing technological landscape.

Prior Art and Related Patents

Prior art refers to existing knowledge and inventions in the same field. Analyzing prior art helps in understanding how the '839 patent innovates and differentiates itself from what already exists.

Patent Landscape

Patent Family

The patent family includes all related patents that claim priority from the same application or are continuations-in-part of each other. For example, in the case of the Cellect patents, each member of the family claims priority from a single application, which can impact their expiration dates and patent term adjustments[1].

Patent Term Adjustments (PTA) and Terminal Disclaimers

PTA can extend the term of a patent due to delays in the USPTO's processing. However, terminal disclaimers, often used to overcome obviousness-type double patenting (ODP) rejections, can affect the adjusted expiration date. The Cellect case illustrates how PTA and terminal disclaimers interact, emphasizing that ODP analysis must consider the adjusted expiration date[1].

Searching and Analyzing Patents

Tools and Resources

To analyze the '839 patent and its landscape, several tools and resources are available:

  • Patent Public Search: This tool provided by the USPTO allows for comprehensive searches of patents and published patent applications[4].
  • Global Dossier: This service provides access to the file histories of related applications from participating IP Offices, helping to identify the patent family and related applications[4].
  • Patent Claims Research Dataset: This dataset contains detailed information on claims from US patents, which can be used to analyze claim-level statistics and document-level statistics[3].

Economic and Legal Implications

Patent Scope and Economic Impact

The scope of a patent, as defined by its claims, has significant economic implications. A broader scope can provide greater protection but may also face more challenges during litigation. The USPTO's Patent Claims Research Dataset can help in measuring patent scope and its economic impact[3].

Legal Considerations

Legal considerations include the potential for litigation, the need for terminal disclaimers to overcome ODP rejections, and the impact of PTA on the patent term. Understanding these aspects is crucial for maintaining and enforcing patent rights.

Expert Insights and Statistics

Industry Experts

Industry experts and legal practitioners often provide valuable insights into the patent landscape. For instance, the study on a small claims patent court by the Administrative Conference of the United States (ACUS) involved consultations with various experts to understand the feasibility and structure of such a court[5].

Statistics

Statistics on patent filings, grants, and litigation can provide a broader context. For example, data from the USPTO can show trends in patent applications and grants, which can help in understanding the competitive landscape.

Key Takeaways

  • Claims Analysis: Understanding the independent and dependent claims is crucial for defining the scope of the invention.
  • Technological Context: Knowing the field of the invention and prior art helps in appreciating the innovation.
  • Patent Landscape: Analyzing the patent family and related patents, along with PTA and terminal disclaimers, is essential for understanding the patent's expiration date and legal implications.
  • Tools and Resources: Utilizing tools like Patent Public Search and the Patent Claims Research Dataset can enhance the analysis.
  • Economic and Legal Implications: The scope of the patent has significant economic and legal implications, including potential litigation and the impact of PTA.

FAQs

  1. What is the significance of independent and dependent claims in a patent? Independent claims define the broad scope of the invention, while dependent claims narrow it down by adding specific features.

  2. How does the USPTO's Patent Public Search tool help in patent analysis? The Patent Public Search tool allows for comprehensive searches of patents and published patent applications, providing enhanced access to prior art and related patents.

  3. What is the impact of Patent Term Adjustments (PTA) on a patent's expiration date? PTA can extend the term of a patent due to delays in the USPTO's processing, but terminal disclaimers can affect the adjusted expiration date.

  4. Why is understanding the patent family important? Understanding the patent family helps in identifying related patents, their expiration dates, and how they interact with each other in terms of PTA and terminal disclaimers.

  5. How can the Patent Claims Research Dataset be used in patent analysis? The dataset provides detailed information on claims from US patents, allowing for the analysis of claim-level statistics and document-level statistics, which can help in measuring patent scope and its economic impact.

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit https://cafc.uscourts.gov/opinions-orders/22-1293.OPINION.8-28-2023_2181381.pdf

  2. U.S. Patent and Trademark Office (USPTO) | USAGov https://www.usa.gov/agencies/u-s-patent-and-trademark-office

  3. Patent Claims Research Dataset - USPTO https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset

  4. Search for patents - USPTO https://www.uspto.gov/patents/search

  5. U.S. Patent Small Claims Court https://www.acus.gov/research-projects/us-patent-small-claims-court

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,252,839

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,252,839

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
02020869Sep 18, 2002
PCT Information
PCT FiledSeptember 04, 2003PCT Application Number:PCT/FI03/00647
PCT Publication Date:April 01, 2004PCT Publication Number: WO2004/026196

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.